Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Honbo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cardiology|December 18, 2009
Doxorubicin cardiomyopathyKanu Chatterjee, Jianqing Zhang, Norman Honbo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 4, 2009
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioningDonald A Vessey, Luyi Li, Norman Honbo, et al.
Journal of Molecular and Cellular Cardiology|May 22, 2007
Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory responseRachid Kacimi, Donald A Vessey, Norman Honbo, et al.
Biochemical and Biophysical Research Communications|July 2, 2008
Vincristine attenuates doxorubicin cardiotoxicityKanu Chatterjee, Jianqing Zhang, Rong Tao, et al.
Cardiovascular Research|February 27, 2007
Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytesRong Tao, Jianqing Zhang, Donald A Vessey, et al.
Medical Science Monitor Basic Research|April 10, 2013
FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioningDonald A Vessey, Luyi Li, Isabella Imhof, et al.
Journal of Molecular and Cellular Cardiology|July 31, 2007
Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stressKanu Chatterjee, Jianqing Zhang, Norman Honbo, et al.
Journal of Cardiovascular Pharmacology|October 1, 2010
Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1Rong Tao, Sun Hee Kim, Norman Honbo, et al.
The Biochemical Journal|October 10, 2002
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersMarina R Bergman, Sunfa Cheng, Norman Honbo, et al.
FEBS Letters|November 17, 2009
Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenaseAlexander B Kotlyar, Antonio Randazzo, Norman Honbo, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cardiology|December 18, 2009
Doxorubicin cardiomyopathyKanu Chatterjee, Jianqing Zhang, Norman Honbo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 4, 2009
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioningDonald A Vessey, Luyi Li, Norman Honbo, et al.
Journal of Molecular and Cellular Cardiology|May 22, 2007
Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory responseRachid Kacimi, Donald A Vessey, Norman Honbo, et al.
Biochemical and Biophysical Research Communications|July 2, 2008
Vincristine attenuates doxorubicin cardiotoxicityKanu Chatterjee, Jianqing Zhang, Rong Tao, et al.
Cardiovascular Research|February 27, 2007
Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytesRong Tao, Jianqing Zhang, Donald A Vessey, et al.
Medical Science Monitor Basic Research|April 10, 2013
FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioningDonald A Vessey, Luyi Li, Isabella Imhof, et al.
Journal of Molecular and Cellular Cardiology|July 31, 2007
Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stressKanu Chatterjee, Jianqing Zhang, Norman Honbo, et al.
Journal of Cardiovascular Pharmacology|October 1, 2010
Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1Rong Tao, Sun Hee Kim, Norman Honbo, et al.
The Biochemical Journal|October 10, 2002
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersMarina R Bergman, Sunfa Cheng, Norman Honbo, et al.
FEBS Letters|November 17, 2009
Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenaseAlexander B Kotlyar, Antonio Randazzo, Norman Honbo, et al.
Pageof 3